ClinicalTrials.gg
RecruitingNCT07207993Updated Jun 15, 2026

Evaluating Health Outcomes of AI-Based Fitness Wearables and App Programs in Older Adults Living Alone With Cognitive Decline

An interventional study of Fitness app for self-efficacy and Social network via app for social support in Older Adults With Cognitive Decline, Older Adults and AI-Based Fitness, sponsored by The University of Tennessee, Knoxville. Recruiting at 2 sites in United States. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-06-15.

Sponsored by The University of Tennessee, Knoxville · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Jun 2026; still recruiting 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
64
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 1,423 studies in Cognitive Dysfunction with a site in United States — 330 open to participants now, 432 under way, 13 of them phase 3. Cognitive Dysfunction · United States.

Planned enrollment
518th of 1,147
64 · median 59
Started
2026
with 96 others
No phase
716 of 1,423
182 open now
Primary completion
2028-06
later than 329 of 431 live
Registered
1,317th of 1,423
by date

Among the 1,423 studies in Cognitive Dysfunction with a site in United States, this one is the 518th largest by planned enrollment of the 1,147 interventional ones that give a count, is one of 97 that started in 2026, is one of 716 with no phase, reaches primary completion later than 329 of the 431 other live ones, and was the 1,317th registered.

Cognitive Dysfunction

3,885 studies on the registry are indexed under Cognitive Dysfunction; 1,123 are open to participants now.

Browse Cognitive Dysfunction studies →

Open to participants now

330 of the 1,423 studies in Cognitive Dysfunction with a site in United States are open now. Recruiting first, the newest first:

325 more — sign in →

All 330 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 751 Cognitive Dysfunction studies recruiting now, 361 (48%) set no upper age limit and 144 (19%) stop at 75 or younger; 46 take children under 18; 260 take healthy volunteers.

This study: 65 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 1,423 studies in Cognitive Dysfunction with a site in United States, or all of them as a file.
02

Study summary

The overarching goal of our research is to develop personalized and accessible healthy aging lifestyle interventions aimed at promoting physical activity (PA) and improving health among community-dwelling older adults living alone with cognitive decline (LACD). To achieve this goal, the purpose of this project is to determine whether wearable and app-based mHealth intervention component(s) will contribute to increased PA and improved health outcomes in older adults LACD. Our specific aims are to: identify and evaluate mHealth intervention components that practically and significantly contribute to enhanced mechanistic outcomes (e.g., self-efficacy, outcome expectations) and increased PA (primary outcome) in older adults LACD over a 6-month period; determine the optimal combinations of intervention components for future efficacy testing; elucidate the mechanism of behavioral change (MoBC) and potential outcomes of these intervention components, namely, the mediating effects of MoBC variables (e.g., self-efficacy, outcome expectations) on the relationship between intervention components and change in PA. The first two aims are primary and fully-powered. The third aim is exploratory. The aims will support a refined, data-driven intervention design for a subsequent larger trial.

Read the detailed description

Mobile health (mHealth) is a promising approach to improving health behaviors, defined as "health services and information delivered or enhanced through the Internet and related technologies." It includes disease prevention and management tools, remote interventions, personalized health monitoring, and mobile healthcare data access. With widespread technology adoption, researchers increasingly use wearable devices and apps to enhance health outcomes by promoting PA and reducing sedentary behavior. Wearable devices and fitness apps are now widely integrated into PA intervention programs, helping individuals adopt more active lifestyles. These tools track steps, activity duration, and progress, providing real-time feedback, goal-setting, and social integration to enhance motivation and behavior regulation. Notably, 21% of U.S. adults regularly use smartwatches or fitness trackers, making them feasible for PA interventions in older adults. RCTs have shown their positive effects on PA, QoL, and psychosocial well-being in older adults though some studies reported modest improvements. Recent advancements in data science and AI-driven mHealth interventions enable scalable, personalized exercise prescriptions. Personalized approaches, particularly those enhancing self-efficacy, yield better outcomes than generalized interventions. However, few studies have leveraged fitness wearables and apps for older adult LACD. This trial addresses this major weakness by implementing an AI-driven mHealth intervention for tailored precision health programs in older adult LACD.

03

Conditions studied

  • Older Adults With Cognitive Decline
  • Older Adults
  • AI-Based Fitness
  • Wearables
  • Cognitive Decline
  • Physical Activity
  • Physical Inactivity

Keywords

  • Older adults
  • Cognitive decline
  • AI-Based Fitness
  • Physical Activity
  • Physical Inactivity
  • Living alone with cognitive decline
  • LACD
  • U.S Older adults
04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participant must be at least 65 years of age older
  • Participant must be living alone in the U.S. for the next 6 months
  • Participant must have report mild cognitive decline [We will use a short self-report AD8 measure of cognitive concerns. Those scoring positive on the AD8 (≥2) will qualify as mild cognitive decline];
  • Participant must own an Android/Apple smartphone
  • Participant must have access to internet or Wi-Fi access
  • Participant must be capable of engaging in some PA as determined by the PA Readiness Questionnaire or physician approval
  • Participant must currently participate in weekly moderate-to-vigorous PA (MVPA) or less than 150 minutes
  • Participant must have basic English communication skills.

Exclusion criteria

Exclusion Criteria:

  • Foreign residents or visitors
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Double (Participant, Investigator)
Enrollment
64 participants (estimated)

Study arms

  • Experimental
    Access to all applications

    Condition 1: Participant are provided with the prescription application (application1), social application (application 2), and health tips application (application 3).

    Other: Fitness app for self-efficacy · Other: Social network via app for social support · Other: Health education app targeting outcome expectations

  • Experimental
    Access to application 1 & 2

    Condition 2: Participant are provided with the prescription application, social application, but they aren't provided with the health tips application.

    Other: Fitness app for self-efficacy · Other: Social network via app for social support

  • Experimental
    Access to application 1 & 3

    Condition 3: Participant are provided with the prescription application, and they aren't provided with the social application, but they are provided with the health tips application.

    Other: Fitness app for self-efficacy · Other: Health education app targeting outcome expectations

  • Experimental
    Access to application 1 only

    Condition 4: Participant are provided with the prescription application, but aren't provided with the social application, and the health tips application.

    Other: Fitness app for self-efficacy

  • Experimental
    Access to application 2 & 3

    Condition 5: Participant are not provided with the prescription application, but they are provided with the social application, and the health tips application.

    Other: Social network via app for social support · Other: Health education app targeting outcome expectations

  • Experimental
    Access to application 2 only

    Condition 6: Participant are not provided with the prescription application, but they are provided with the social application, and they aren't provided with the health tips application.

    Other: Social network via app for social support

  • Experimental
    Access to application 3 only

    Condition 7: Participant are not provided with the prescription application, or the social application, but they are provided with the health tips application.

    Other: Health education app targeting outcome expectations

  • No intervention
    No access to any application

    Condition 8: Participant are not provided with the prescription application, or the social application, or with the health tips application.

Interventions

  • OtherFitness app for self-efficacy

    AI-driven personalized exercise prescription via a fitness app. This targets self-efficacy.

  • OtherSocial network via app for social support

    Participants will be provided access to a social network via app. This targets social support.

  • OtherHealth education app targeting outcome expectations

    Participants are provided with an app-based health education. This targets outcome expectations.

06

What researchers measure

Primary outcomes

  1. Fitbit MVPA

    Fitbit Inspire 3 Tracker will be used to assess participants' MVPA (active time which includes both fairly active time and very active time). Fairly active; duration associated with light intensity activities, i.e., walking, light cycling, housework (\~3-6 METs). Very active; duration associated with high intensity activities, i.e., running, aerobic workouts (\>6 METs).

    Time frame: Baseline (i.e., pre-intervention), 3 months (mid-point), and 6 months (end-point).

  2. Physical Activity

    We will use the Physical Activity Scale for the Elderly to assess PA. Higher scores means more physical activity. (Low activity: \<100; Moderate: 100-250; High: \>250)

    Time frame: Baseline (i.e., pre-intervention), 3 months (mid-point), and 6 months (end-point).

  3. Mechanism of behavior change (MoBC) variables

    Psychometrically validated questionnaires will be used to assess beliefs: self-efficacy, social support, and outcome expectations. Self-efficacy; low score indicates low confidence in ability to perform behavior, high score indicates strong confidence. Social support; low score indicates poor support from family or friends, high score indicates great support. Outcome expectation; low score indicates the belief that behavior won't help, high score indicates the belief that the behavior will lead to positive outcome.

    Time frame: Baseline (i.e., pre-intervention), 3 months (mid-point), and 6 months (end-point).

Secondary outcomes

  1. Quality of life (QoL)

    We will select the brief Older People's Quality of Life questionnaire to assess quality of life (OPQOL-BRIEF). Minimum: 13 (very poor quality of life) Maximum: 65 (excellent quality of life)

    Time frame: Baseline (i.e., pre-intervention), 3 months (mid-point), and 6 months (end-point).

  2. Psychosocial wellbeing

    We will assess wellbeing using the World Health Organization Well-Being Index (WHO-5) questionnaire. 0 -12 - Low well-being; possible depression (screen positive) 13 - 19 - Moderate well-being 20 - 25 - High well-being

    Time frame: Baseline (i.e., pre-intervention), 3 months (mid-point), and 6 months (end-point).

  3. Cognition

    To assess older adults' cognition (thinking and memory), we will use the 5-minute Montreal Cognitive Assessment (MoCA). 26 - 30: Normal; Indicates health cognitive functioning for most adults. 18 - 25: Mild Cognitive Impairment (MCI); Shows noticeable memory or thinking issues that do not severely disrupts daily life. 10 - 17: Moderate Cognitive Impairment; Suggests a heightened progression towards early-to-mid stage dementia. Less than 10: Severe Cognitive Impairment.

    Time frame: Baseline (i.e., pre-intervention), 3 months (mid-point), and 6 months (end-point).

07

Study locations

1 of 2 sites recruiting
  • University of Tennessee
    Knoxville, Tennessee 37920, United States
    Not yet recruiting
    • Kinesiology, Recreation, and Sport Studies · Contactkrss@utk.edu · (865) 974-3340
    • Zan Gao, PhD · Principal investigator
    • Danielle Ostendorf, PhD · Sub investigator
    • Xiaopeng Zhao, PhD · Sub investigator
    • Jeffrey Labban, PhD · Sub investigator
  • The University of Tennessee, Knoxville. Health, Recreation, and Physical Education Building
    Knoxville, Tennessee 37996, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2026 (actual). Primary completion is estimated for Jun 2028, 24 months after the start.

Of 1,453 non-industry interventional studies with no phase under Cognitive Dysfunction, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 51. This study's planned 24 months is below that.

Counting every sponsor, half of 1,522 studies reached it within 27 months; a quarter within 12 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 19, 2025
First posted
Oct 6, 2025
StartActual
Jun 8, 2026
Primary completionEst.
Jun 8, 2028
CompletionEst.
Jun 8, 2028
Last update
Jun 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07207993
Lead sponsor
The University of Tennessee, Knoxville
Collaborators
Arizona State University, Oregon Research Institute, National Institute on Aging (NIA)
Responsible party
Zan Gao (Professor and Department Head, The University of Tennessee, Knoxville) — Principal investigator
First posted
Oct 6, 2025
Start date
Jun 8, 2026
Primary completion
Jun 8, 2028 (estimated)
Completion
Jun 8, 2028 (estimated)
Last update
Jun 15, 2026

Study contacts

Zan Gao, PhD
Contact
zan@utk.edu
865-974-7971

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion